1. Home
  2. MDXH vs FGBI Comparison

MDXH vs FGBI Comparison

Compare MDXH & FGBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • FGBI
  • Stock Information
  • Founded
  • MDXH 2003
  • FGBI 1934
  • Country
  • MDXH Belgium
  • FGBI United States
  • Employees
  • MDXH N/A
  • FGBI N/A
  • Industry
  • MDXH
  • FGBI Savings Institutions
  • Sector
  • MDXH
  • FGBI Finance
  • Exchange
  • MDXH Nasdaq
  • FGBI Nasdaq
  • Market Cap
  • MDXH 141.1M
  • FGBI 121.5M
  • IPO Year
  • MDXH 2021
  • FGBI N/A
  • Fundamental
  • Price
  • MDXH $3.55
  • FGBI $8.42
  • Analyst Decision
  • MDXH Buy
  • FGBI
  • Analyst Count
  • MDXH 1
  • FGBI 0
  • Target Price
  • MDXH $6.00
  • FGBI N/A
  • AVG Volume (30 Days)
  • MDXH 172.3K
  • FGBI 6.2K
  • Earning Date
  • MDXH 08-05-2025
  • FGBI 08-18-2025
  • Dividend Yield
  • MDXH N/A
  • FGBI 0.47%
  • EPS Growth
  • MDXH N/A
  • FGBI N/A
  • EPS
  • MDXH N/A
  • FGBI N/A
  • Revenue
  • MDXH $98,953,000.00
  • FGBI $59,070,000.00
  • Revenue This Year
  • MDXH $24.77
  • FGBI N/A
  • Revenue Next Year
  • MDXH $22.21
  • FGBI $3.38
  • P/E Ratio
  • MDXH N/A
  • FGBI N/A
  • Revenue Growth
  • MDXH 22.56
  • FGBI N/A
  • 52 Week Low
  • MDXH $1.35
  • FGBI $6.56
  • 52 Week High
  • MDXH $3.81
  • FGBI $15.25
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 73.83
  • FGBI 56.99
  • Support Level
  • MDXH $2.86
  • FGBI $7.91
  • Resistance Level
  • MDXH $3.81
  • FGBI $8.09
  • Average True Range (ATR)
  • MDXH 0.22
  • FGBI 0.22
  • MACD
  • MDXH 0.05
  • FGBI 0.04
  • Stochastic Oscillator
  • MDXH 78.15
  • FGBI 100.00

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About FGBI First Guaranty Bancshares Inc.

First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.

Share on Social Networks: